REGISTERED NUMBER: 08869155 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2026

FOR

DR AK MARNERIDES LTD

Page

Company Information

1

Statement of Financial Position

2

DIRECTORS:

Dr A K Marnerides

Ms A Pieri

REGISTERED OFFICE:

869 High Road

London

N12 8QA

REGISTERED NUMBER:

08869155 (England and Wales)

ACCOUNTANTS:

Beavis Morgan LLP

869 High Road

London

N12 8QA

FIXED ASSETS

32,212

295,360

CURRENT ASSETS

296,860

72,711

CREDITORS

Amounts falling due within one year

(98,232

)

(46,856

)

NET CURRENT ASSETS

198,628

25,855

TOTAL ASSETS LESS CURRENT LIABILITIES

230,840

321,215

CAPITAL AND RESERVES

230,840

321,215

NOTES TO THE FINANCIAL STATEMENTS

1.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2025 - 1 ) .

2.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 January 2026 and 31 January 2025:

2026

2025

£

£

Dr A K Marnerides

Balance outstanding at start of year

-

-

Amounts advanced

636,234

-

Amounts repaid

(389,128

)

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

247,106

-

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 20 October 2026 and were signed on its behalf by:

Dr A K Marnerides - Director